ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/TIRZEPATIDE INTERMEDIATE P7
C121H181N13O27
2249.8 g/mol
Pharmaceutical Intermediate

TIRZEPATIDE INTERMEDIATE P7

CAS2461524-70-7
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

This compound is a fully protected peptide intermediate used in the manufacturing of tirzepatide. It contains multiple amide bonds, ester groups, and ether linkages, with a high molecular weight and extensive hydrophobic character.

Synthetic intermediate in tirzepatide peptide assemblyPharmaceutical research and development

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing TIRZEPATIDE INTERMEDIATE P7?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

L-Phenylalanine benzyl ester hydrochloride

CAS2462-32-0

pharmaceutical intermediate

ReferenceSame Category

L-Valine benzyl ester hydrochloride

CAS2462-34-2

pharmaceutical intermediate

ReferenceSame Category

Benzyl L-leucinate--hydrogen chloride (1/1)

CAS2462-35-3

pharmaceutical intermediate

ReferenceSame Category

3-Amino-2,6-piperidinedione hydrochloride

CAS24666-56-6

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoyl]amino]-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoyl]amino]-3-methylpentanoyl]amino]propanoyl]amino]-5-oxo-5-(tritylamino)pentanoyl]amino]-6-[[2-[2-[2-[[2-[2-[2-[[(4S)-5-[(2-methylpropan-2-yl)oxy]-4-[[20-[(2-methylpropan-2-yl)oxy]-20-oxoicosanoyl]amino]-5-oxopentanoyl]amino]ethoxy]ethoxy]acetyl]amino]ethoxy]ethoxy]acetyl]amino]hexanoyl]amino]propanoic acid

InChIKey

GISIFDOJKAHZER-CJOLIZTOSA-N

SMILES

CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)NC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)N[C@@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](C(=O)OC(C)(C)C)NC(=O)CCCCCCCCCCCCCCCCCCC(=O)OC(C)(C)C)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCCCNC(=O)OC(C)(C)C)NC(=O)[C@H](CC(=O)OC(C)(C)C)NC(=O)OCC4C5=CC=CC=C5C6=CC=CC=C46

Synonyms (2)
  • TIRZEPATIDE INTERMEDIATE P7
  • Tirzepatide Impurity 2

Sourcing TIRZEPATIDE INTERMEDIATE P7?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→